Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

PPCB

PPCB News

Newswire

09:02

Propanc Biopharma shares surge 10.68% premarket as PRP’s mesenchymal drift research advances, patent filed, and 2026 Phase 1b trial planned.

09:02

Propanc to investigate "mesenchymal drift" for chronic disease reversal.

16:08

Propanc Biopharma shares fall 14.57% after-hours after reporting wider Q1 loss of $0.39 vs. $0.36 last year.

12:41

Propanc Biopharma shares surge 31.99% intraday after filing provisional patents for resistant cancer and fibrosis treatments.

09:35

Propanc Biopharma shares rise 10.96% intraday after submitting Spain patents for resistant cancer and fibrosis treatments.

View More

About PPCB

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More